Cancer stem-like cells and thyroid cancer.
Thyroid cancer is one of the most rapidly increasing malignancies. The reasons for this increase is not completely known, but increases in the diagnosis of papillary thyroid microcarcinomas and follicular variant of papillary thyroid carcinomas along with the enhanced detection of well-differentiated thyroid carcinomas are probably all contributing factors. Although most cases of well-differentiated thyroid carcinomas are associated with an excellent prognosis, a small percentage of patients with well-differentiated thyroid carcinomas as well as most patients with poorly differentiated and anaplastic thyroid carcinomas have recurrent and/or metastatic disease that is often fatal. The cancer stem-like cell (CSC) model suggests that a small number of cells within a cancer, known as CSCs, are responsible for resistance to chemotherapy and radiation therapy, as well as for recurrent and metastatic disease. This review discusses current studies about thyroid CSCs, the processes of epithelial-to-mesenchymal transition (EMT), and mesenchymal-to-epithelial transition that provide plasticity to CSC growth, in addition to the role of microRNAs in CSC development and regulation. Understanding the biology of CSCs, EMT and the metastatic cascade should lead to the design of more rational targeted therapies for highly aggressive and fatal thyroid cancers.
Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public Health, Zhejiang, China.
Zhenying
Z
Guo
Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public Health, Zhejiang, China.
Heather
H
Hardin
Department of Pathology and Laboratory MedicineUniversity of Wisconsin School of Medicine and Public Health, Zhejiang, China rvlloyd@wisc.edu.
Ricardo V
RV
Lloyd
D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism; D058750:Epithelial-Mesenchymal Transition; D053823:Hedgehog Proteins / Q000378:metabolism; D006801:Humans; D035683:MicroRNAs / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000378:metabolism; D051880:Receptors, Notch / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000235:genetics / Q000378:metabolism; D059016:Tumor Microenvironment; D060449:Wnt Signaling Pathway
D014408:Biomarkers, Tumor; D053823:Hedgehog Proteins; D035683:MicroRNAs; D051880:Receptors, Notch
EMT; cancer stem cells; microRNA; microenvironment; signal pathway; thyroid cancer